Responses
Cancer genetics
Short Report
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
Compose a Response to This Article
Other responses
No responses have been published for this article.